Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Archer Stock Eyes Q1 Earnings After UAE Updates

Archer Aviation's strategic COO appointment for UAE operations signals a commitment to its imminent Middle East launch, building on recent stock momentum.

Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx Boost

Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx Boost

Broadcom just got big news from several Magnificent Seven stocks. This includes key customers for Broadcom's AI chips. One is looking to spend even more on AI.

Ford Motor Stock Rises After Earnings, But Momentum May Not Last

Ford Motor Stock Rises After Earnings, But Momentum May Not Last

Ford Motor reported better-than-expected earnings but the company faces an uncertain year reflected in a lack of forward guidance amid tariff concerns

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Lemonade Delivers Sweet Results, Price Reversal to Accelerate

AI-powered insurance provider Lemonade is on track to reach profitability next year and may exceed forecasts in 2025 because of increasing leverage.

Is Intel Stock a Bargain or a Burden? Cheap Stock, High Stakes

Despite a low stock valuation, Intel's conservative forecast following their recent earnings report has led to uncertain investor sentiment.

3 Mid-Cap Medical Stocks Outperforming the Market

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

The Top-Ranked Insider Buys From April by Market Cap

Insiders are buying stock in 2025, and the purchases are not limited to a single market cap, sector, or industry. Analysts see deep value in these stocks.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Shares of Eli Lilly just got walloped. So, is the company still the name to own in GLP-1s, or are the tables turning on this pharma giant?

Hims & Hers Stock Rises on Fundamentals and Squeeze Potential

Hims & Hers Stock Rises on Fundamentals and Squeeze Potential

Hims & Hers stock is now giving investors another reason to consider it a buy for the coming months, as the latest quarterly earnings show momentum.

Microsoft Stock After Xbox Price Hike: Buy or Hold?

Microsoft Stock After Xbox Price Hike: Buy or Hold?

Microsoft will be increasing prices for its popular Xbox Series due to rising tariff-related production; that's bad news for consumers but not for investors

Top 3 Sectors Where Valuations Are Most Below Market Levels

Top 3 Sectors Where Valuations Are Most Below Market Levels

See these three ETFs that closely track three S&P 500 sectors that are trading well below the market based on their forward price-to-earnings ratios.

Dividends & Stability: 3 Consumer Staples Giants Boost Payouts

Dividends & Stability: 3 Consumer Staples Giants Boost Payouts

Three huge names in the consumer staples sector just announced substantial dividend increases providing a source of consistent return in volatile times.

Palantir Stock Drops Despite Stellar Earnings: What's Next?

Palantir Stock Drops Despite Stellar Earnings: What's Next?

Despite a strong earnings report, Palantir's stock dropped over 9%, raising questions about the company's lofty valuation even with the impressive growth

D-Wave Quantum: Hidden Opportunity or Short Seller's Dream?

D-Wave Quantum: Hidden Opportunity or Short Seller's Dream?

D-Wave Quantum has generated significant hype for its role in the development of quantum computing tech, but a short seller perspective may be gaining traction.

Get all your
news in one place.

100’s of premium titles.
One news app.

Uncertainty Creates Opportunity for Tyson Foods Investors

Tyson Foods' stock price provides an attractive entry point for investors looking to expand their positions or initiate new ones in high-yielding stocks.

Why Wells Fargo Is Buying $40 Billion of Its Own Stock

Wells Fargo just approved a $40 billion buyback program for its own stock, giving investors some signs of potential rebounds and rallies in the future.

It's Not Too Late to Jump on These Under-the-Radar Momentum Plays

These three stocks may fly under the radar, but their recent price increases could appeal to investors seeking a momentum play.

Chevron’s Fundamentals Shine Through Market Turmoil

Chevron delivered mixed earnings that highlight the cyclical nature of its business, but the company's solid fundamentals suggest this is a buying opportunity

Get all your
news in one place.

100’s of premium titles.
One news app.

Qualcomm: Analyst Opinions Split, But Upside Potential Remains

Qualcomm’s valuation is compelling and growth drivers are solid, but mixed analyst sentiment will keep investors guessing - for now.

Monster Beverage Stock: Short Report Risks vs Upside Potential

Monster Beverage is on track for new highs despite a short report from Spruce Pine that highlights numerous headwinds in 2025,

Onsemi Stock Confirms Bottom, But What’s the Upside?

Onsemi's stock price correction reached bottom in April and is on track to begin rebounding in 2025, and it only needs a catalyst to drive it.

3 Tech Leaders Announce Buybacks Totaling $85 Billion

Tech buybacks are something that investors have come to expect, and three huge tech names are boosting their share buyback programs in Q1 2025.

3 Stocks to Watch as Bitcoin Nears $100k Again

Now that Bitcoin has started on a new bull run along with the S&P 500, three stocks in this space stand out as attractive buys for investors today

Amazon: Why The Great Comeback Rally Could Be About to Begin

Amazon beat Q1 expectations and analysts are very much bullish, with some price targets calling for almost 50% upside from current levels.

3 Reasons Tesla Should Be a $300 Stock by June

Tesla’s rally is accelerating post-earnings, as bullish analyst targets, rising momentum, and risk-on sentiment all push shares toward $300.

1 … 111 112 113 114

People

167,208 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

341,325 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play